Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 24:10:3127-35.
doi: 10.3762/bjoc.10.330. eCollection 2014.

Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels

Affiliations

Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels

César A Estévez et al. Beilstein J Org Chem. .

Abstract

All mammals lose their ability to produce lactase (β-galactosidase), the enzyme that cleaves lactose into galactose and glucose, after weaning. The prevalence of lactase deficiency (LD) spans from 2 to 15% among northern Europeans, to nearly 100% among Asians. Following lactose consumption, people with LD often experience gastrointestinal symptoms such as abdominal pain, bowel distension, cramps and flatulence, or even systemic problems such as headache, loss of concentration and muscle pain. These symptoms vary depending on the amount of lactose ingested, type of food and degree of intolerance. Although those affected can avoid the uptake of dairy products, in doing so, they lose a readily available source of calcium and protein. In this work, gels obtained by complexation of Tetronic 90R4 with α-cyclodextrin loaded with β-galactosidase are proposed as a way to administer the enzyme immediately before or with the lactose-containing meal. Both molecules are biocompatible, can form gels in situ, and show sustained erosion kinetics in aqueous media. The complex was characterized by FTIR that evidenced an inclusion complex between the polyethylene oxide block and α-cyclodextrin. The release profiles of β-galactosidase from two different matrices (gels and tablets) of the in situ hydrogels have been obtained. The influence of the percentage of Tetronic in media of different pH was evaluated. No differences were observed regarding the release rate from the gel matrices at pH 6 (t 50 = 105 min). However, in the case of the tablets, the kinetics were faster and they released a greater amount of 90R4 (25%, t 50 = 40-50 min). Also, the amount of enzyme released was higher for mixtures with 25% Tetronic. Using suitable mathematical models, the corresponding kinetic parameters have been calculated. In all cases, the release data fit quite well to the Peppas-Sahlin model equation, indicating that the release of β-galactosidase is governed by a combination of diffusion and erosion processes. It has been observed that the diffusion mechanism prevails over erosion during the first 50 minutes, followed by continued release of the enzyme due to the disintegration of the matrix.

Keywords: controlled release; cyclodextrins; lactase; polypseudorotaxane; supramolecular gel.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Inclusion complex (polypseudorotaxane) between α-cyclodextrins and reverse Tetronics.
Figure 2
Figure 2
90R4/α-CD gels loaded with lactase. Octablock Tetronic molecules (grey) are threaded by CDs (red) forming a supramolecular assembly that entraps the protein molecules (blue).
Figure 3
Figure 3
FTIR spectra of Tetronic 90R4, α-CD, lactase and T25a10 complex.
Figure 4
Figure 4
Release profiles of lactase from T25a10 (open circles) and T15a10 (filled circles) at pH 6 from a) gels with 29452 ALU, b) tablets with 4000–4500 ALU, c) tablets with 500–900 ALU and d) tablets with 4000–4500 ALU from pH 1.2 to pH 6 (d). ALU: acid lactase units.
Figure 5
Figure 5
Contribution of diffusion (open circles) and erosion (filled circles) mechanisms from polymers a) T25a10 and b) T15a10 regarding the delivery of lactase.
Figure 6
Figure 6
Chemical structure of a reverse Tetronic.

References

    1. Alliende F G. Gastroenterol Latinoam. 2007;18:152–156.
    1. Ratzinger G, Wang X, Wirth M, Gabor F. J Controlled Release. 2010;147:187–192. doi: 10.1016/j.jconrel.2010.04.017. - DOI - PubMed
    1. Squillante E, Morshed G, Bagchi S, Mehta K A. J Microencapsulation. 2003;20:153–167. doi: 10.3109/02652040309178058. - DOI - PubMed
    1. Hensley A L. [Jul 4;2014 ];The enzyme β-galactosidase: structure and function. Available from: http://chemistry.berea.edu/~biochemistry/2008/ah.
    1. Benevides C. Ingeniería de biocatalizadores y bioprocesos: beta-galactosidasa de Thermus sp., cepa T2. Spain: Universidad Politécnica de Madrid; 2002.

LinkOut - more resources